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Abstract
An association between maternal IgG antibodies reactive against proteins in fetal brain and
an outcome of autism in the child has been identified. Using a mouse model of prenatal intra-
ventricular administration of autism-specific maternal IgG, we demonstrated that these anti-
bodies produce behavioral alterations similar to those in children with ASD. We previously
demonstrated that these antibodies bind to radial glial stem cells (RG) and observed an
increase in the number of divisions of translocating RG in the developing cortex. We also
showed an alteration in brain size and as well as a generalized increased of neuronal vol-
ume in adult mice. Here, we used our intraventricular mouse model of antibody administra-
tion, followed by Golgi and Neurolucida analysis to demonstrate that during midstages of
neurogenesis these maternal autism-specific antibodies produced a consistent decrease in
the number of spines in the infragranular layers in the adult cortical areas analyzed. Specifi-
cally, in the frontal cortex basal dendrites of layer V neurons were decreased in length and
volume, and both the total number of spines—mature and immature—and the spine density
were lower than in the control neurons from the same region. Further, in the occipital cortex
layer VI neurons presented with a decrease in the total number of spines and in the spine
density in the apical dendrite, as well as decrease in the number of mature spines in the api-
cal and basal dendrites. Interestingly, the time of exposure to these antibodies (E14.5) coin-
cides with the generation of pyramidal neurons in layer V in the frontal cortex and in layer VI
in the occipital cortex, following the normal rostro-caudal pattern of cortical cell generation.
We recently demonstrated that one of the primary antigens recognized by these antibodies
corresponds to stress-induced phosphoprotein 1 (STIP1). Here we hypothesize that the
reduction in the access of newborn cells to STIP1 in the developing cortex may be responsi-
ble for the reduced dendritic arborization and number of spines we noted in the adult cortex.
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Introduction
Autism spectrum disorders (ASD) are defined by a pattern of qualitative abnormalities in
reciprocal social interaction, communication, and repetitive interests and behaviors. Recent
estimates indicate that 1 in 68 children in the United States are impacted by ASD [1]. Identi-
fied regions of the brain that are affected in ASD include the cerebral cortex and the cerebel-
lum [2, 3]. Neuropathological changes in affected brain areas include alterations in cell
numbers and connectivity [4–6]. These alterations are produced by prenatal and postnatal
changes in the normal patterns of cortical development, including stem cell function and neur-
ite outgrowth [7].
Maternal IgG isotype antibodies cross the placenta beginning by week 17 of gestation to
equip the immunologically naïve fetus with a subset of antibodies that provide protection
against a myriad of possible infectious agents [8]. These maternal IgG antibodies are known to
persist for up to 10 weeks after birth [9]. However, together with immunoprotective IgG anti-
bodies, autoantibodies that react to fetal ‘self’-proteins can also cross the placenta. Gestational
transfer of maternal autoantibodies with reactivity to fetal proteins is an established cause of
congenital abnormalities in the context of maternal autoimmune disorders. Therefore, brain-
reactive antibodies have the potential to exert substantial effects on the fetal brain through
their interaction with target antigens. This interaction can take several forms including recep-
tor activation, receptor blockade, and/or reducing the effective level of a soluble protein.
Recently, a strong association between maternal IgG antibodies reactive against proteins in
fetal brain (MAUab) and an outcome of autism in the child, has been independently identified
by several groups [10, 11]. A particular pattern of reactivity to fetal brain proteins at approxi-
mately 37 and 73 kDa was initially observed uniquely among mothers of children with ASD
[12]. This same pattern of reactivity was observed in prospectively collected mid-gestation
blood samples from mothers who went on to have a child with autism [13], supporting the
possibility that these antibodies may directly affect neurodevelopment in utero. We have previ-
ously demonstrated that maternal autoantibodies are reactive to the identical proteins in both
human and mouse fetal brain. Our more recent studies demonstrate, for the first time, that lac-
tate dehydrogenase A and B (LDH), stress-induced phosphoprotein 1 (STIP1), and collapsin
response mediator protein 1 (CRMP1) comprise the primary antigens corresponding to the
previously described 37 and 73 kDa (doublet) proteins recognized by MAUab [14]. Further,
ASD children from mothers with specific reactivity to LDH, STIP1 and CRMP1 have elevated
stereotypical behaviors compared to ASD children from mothers lacking these antibodies[15].
Using a mouse model of prenatal intraventricular administration of MAUab, we have dem-
onstrated that these produce behavioral alterations similar to those in human autism [16, 17].
We have also demonstrated a strong link between maternal autoantibodies and fetal brain
development, since these antibodies bind to radial glial (RG) stem cells, the primary neural
stem cell in most regions of the developing brain. Consequently, we observed an increase in
the number of divisions of translocating RG cells in the subventricular zone of the developing
cortex. Based on these data, we proposed that maternal autoantibodies are reducing the length
of the neurogenic period in the cerebral cortex and ganglionic eminence. In addition, we
showed an alteration in brain size and weight in the adult mice prenatally exposed to these
autoantibodies, as well as a generalized increased of neuronal volume. We hypothesized that
the alteration in brain and neuronal volume could be due to several factors such as an alter-
ation of dendritic arbors and/or an accumulation of products of cellular degeneration [16].
Dendrites and spines are the main neuronal structures receiving input from other neurons
and glial cells, and their number and morphology is one of the crucial factors determining
how signals coming from individual synapses are integrated. Dendrites contain dendritic
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spines that are microscopic membrane protrusions comprising the receptive postsynaptic
compartment of excitatory synapses in the brain [18, 19]. Spine morphology, number and den-
sity are crucial factor determining the strength and stability of the synaptic transmission[20–
24]. Dendrites of a single neuron can contain hundreds to thousands of spines and a typical
mature spine has a single synapse located at its head. Dendrite and spine modifications have
been described in many disease states, however much remains to be understood about the
characteristics of neuronal dendrites and dendritic spines in autism and related disorders.
Based on its morphology, dendritic spines have been classified as thin, stubby, and mushroom,
among others [25]. Spines are classified into specific morphologies based on the spine’s head
to neck diameter ratio. For example, mushrooms spines have a large head and a narrow neck,
stubby spines have no obvious constriction between the head and the attachment to the shaft,
and thin spines have a smaller head and a narrow neck [26]. Spine morphology is related with
function. Mushrooms and stubby spines are considered mature spines because they are stable,
persist for long periods of time, and form strong excitatory synapses [27, 28], while thin spines
are considered immature because there are highly motile, unstable, and often short-lived, rep-
resenting weak or silent synapses [29]. Filopodia are long and thin protrusions that are precur-
sors to spines.
Currently much remains to be learned about the characteristics of neuronal dendrites in
individuals with autism. The data collected from human tissue is scarce but suggest that an
alteration in dendritic and spine density is related to the pathogenesis of autism [30–34]. Wil-
liams et al. specifically quantified spines in the human cerebral cortex. However, this study was
limited to 4 cases of autism with mental retardation and only two cases presented with qualita-
tively decreased spine densities. In addition, one of the cases suffered from uncontrolled sei-
zures [32]. On the other hand, Hutsler et al. identified spine density increases in apical and
basal dendrites of pyramidal neurons located in the in the superficial layers of the frontal, tem-
poral and parietal lobes, and in the apical dendrites of layer V in the temporal lobe. Not all the
10 ASD cases presented with this increase in spine density, but high spine densities were asso-
ciated with decreased brain weights and were most commonly found in ASD subjects with
lower levels of cognitive functioning [34]. Spine number and size may be dependent on the
area of cortex, the cortical layer, and the age of the individual examined, among other vari-
ables. It is also possible that since autism is a very heterogeneous syndrome, different individu-
als present with different dendrite and spine modifications. Data collected from autism-like
mouse models also present with an alteration in dendritic and spine density and may reflect an
impairment in the developmental organizational processes of synapse stabilization and elimi-
nation, or pruning [30].
Here, we investigated the presence of a potential alteration in the dendritic arbor and spine
population in adult mice prenatally exposed to autism-specific maternal autoantibodies. We
utilized our intraventricular model of maternal autoantibody administration [16, 17] and,
using the Golgi method and Neurolucida, determined the morphology of the dendritic arbor
including the number and type of dendritic spines in each layer of the cerebral cortex of
treated animals.
Materials and methods
We randomly assigned pregnant dams to MAUab or MTDab administration on embryonic day
14. Pups were born, and when adult (8 weeks of age, n = 5 per group) were perfused, their
brains were extracted and Golgi staining was performed. Once Golgi was finalized and 100 μm
sections cut, we selected a pyramidal neuron within each of the supragranular (II-III) and
infragranular layers (IV-V) in both prefrontal and occipital cortices from each animal. In total
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80 neurons were analyzed. Using Neurolucida we traced the pyramidal neuron’s body, den-
drites and spines. Each dendrite was traced using a different color. Spines were classified in
thin and mature spines. Thin spines included long spines with no head including thin spines
and filopodia. Mature spines included spines with stubby and mushroom morphology. We
analyzed data obtained for apical and basal dendrites separately. Specifically, we quantified the
number of basal dendrites, the total length and volume of apical and basal dendrites, the num-
ber of dendrite terminations and bifurcations of apical and basal dendrites, as well the number
of type-specific spines.
Plasma samples
For this study, maternal samples were obtained from the CHARGE Study at the University of
California, Davis M.I.N.D. Institute. To be eligible for study participation, the children of the
maternal samples used were between the ages of 24 and 60 months at the time of enrollment,
and the maternal postnatal sample was acquired at this time. This study protocol followed the
ethical guidelines of the most recent Declaration of Helsinki and was approved by the institu-
tional review boards at the University of California, Davis, and the State of California Office of
Human Research Protection. Informed consent of the mothers was obtained prior to parti-
cipation in the study. All study participants received a subject identification number and all
personal identifiers were removed from the sample prior to use in the study. Following charac-
terization of the maternal autoantibody profile by fetal brain western blot, IgG was purified
from plasma under sterile conditions using Protein A/G columns and dialyzed against sterile
saline. Prepared IgG samples were tested for bacterial contamination using an LPS-detecting
turbidity assay, and only samples verified to be sterile and pyogen free were used. The experi-
mental group included embryos injected with IgG obtained from plasma from a mother of a
child with autism who had a high titer of IgG reactivity to the 37- kDa (lactate dehydrogenase
or LDH) and 73-kDa (stress-induced phosphoprotein 1 or STIP1, and collapsin response
mediator protein 1 or CRMP1) fetal brain proteins (MAUab), that was used in our previous
studies [6, 17]. In the control group embryos were injected with IgG isolated from plasma
from a mother of a typically developing child who did not have fetal brain-reactive IgG
(MTDab). Embryos in two pregnant animals were injected per group.
Animals
The UC Davis Institutional Animal Care and Use Committee approved all experiments
included here. Animals were housed in cages containing 4 mice with food and water ad libi-
tum. Food, water, temperature, humidity, ventilation, and light cycle were check and hus-
bandry records collected daily. We carefully observed animals for changes in health status,
including for pain and distress. Signal of pain and distress included change in body weight,
external physical appearance, clinical signs (e.g., inability to reach food and water, lethargy or
decreased mental alertness, labored breathing, inability to remain upright), and/or significant
changes in behavior. No mice presented with conditions that resulted in significant pain that
could not be alleviated by analgesics. Mice were euthanized using a lethal dose of anesthetic
(4% isoflurane) and perfused using intracardiac perfusion of saline solution. Pregnant adult
female Swiss Webster mice were purchased from Charles River. We used female Swiss Webster
because, based in our previous experience [35–37], embryos from this strain are easier to inject
in utero and the survival rate is higher than that in other mice strains. All animals were housed
at the University of California, Davis animal facilities. The number of animals used in each
experiment was minimized.
Maternal antibodies effect in dendrite and spines
PLOS ONE | https://doi.org/10.1371/journal.pone.0183443 August 18, 2017 4 / 13
Antibody administration
Pregnant dams were randomly assigned to injection of MAUab or to injection of MTDab.
Timed pregnant mice were anesthetized on embryonic day (E)14, an abdominal incision made
through the skin and the abdominal muscular layer, and temporarily exposed the uterine
horns. 0.5–1.0 μL containing 10 μg of purified MAUab or MTDab was then injected directly
into the cerebral ventricle of each embryo by passing a 33-gauge micropipette through the
uterine wall and into the cerebral ventricle. All pups were injected in each pregnant dam. The
uterine horns were replaced, and the muscular layer and skin sutured closed.
Golgi
We post-fixed tissue blocks encompassing layer I to VI with PFA and 1.5% picric acid in 0.1 M
PBS for 24h, rinsed them with PBS, transferred them to a 0.02% osmium tetroxide solution in
PBS for 10–30 min under gentle shaking in the dark, rinsed again, and immersed them in 3%
potassium dichromate in deionized water in the dark at 4˚C for 24h. We cut the whole cortex
in 100 μm sections and gently placed them in the impregnation solution of 1.5% silver nitrate
at room temperature (RT) in the dark for 24 h. After that period, we rinsed and mounted sec-
tions on gelatin-coated slides, dried slices at RT and dehydrated in ascending series of ethanol,
cleared in xylene, mounted with non-acidic synthetic balsam, and dried at RT for 24h[38, 39],
Fig 1.
Neurolucida
We selected six pyramidal neurons in the frontal cortex and six pyramidal neurons in the
occipital cortex of each mouse brain, one neuron per layer. Researcher was blinded to diagno-
sis. We considered as frontal cortex the 3 most rostral sections in the frontal pole and occipital
cortex the 3 most caudal sections located in the occipital pole. We identified pyramidal neu-
rons by their characteristic triangular soma and apical dendrites extending toward the pial sur-
face. Neuron were chosen based on their presence of a complete Golgi impregnation of
dendrites and spines with a limited amount of staining artifacts. We scanned each neuron
under 60x oil immersion magnification by varying the depth of the Z plane. We generated
bidimensional reconstructions of the three-dimensional dendritic tree including spines for
each neuron, Fig 2. We used Neurolucida 7.5 software (MBF Bioscience) and an Olympus
microscope equipped with a high-resolution digital camera, a mechanical stage, and an x-y-z
axis encoder.
Fig 1. Golgi-stained dendrites. A. Basal dendrites in frontal cortex layer V of MTDab and MAUab treated
mice. B. Apical dendrites in occipital cortex layer VI of MTDab and MAUab treated mice. C. Basal dendrites in
occipital cortex layer VI of MTDab and MAUab treated mice. D. Representative morphology of spines classified
as mature (*) and thin (+). Scale bar: A-C: 2.5 μm; D. 0.25 μm.
https://doi.org/10.1371/journal.pone.0183443.g001
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Fig 2. Neurolucida reconstruction of representative pyramidal neurons in infragranular layers of the cortex of MTDab and MAUab treated
mice. A-F: Frontal cortex. G-L: Occipital cortex. Somata are in blue, apical dendrites in yellow, axonal initial segments in green, and basal dendrites in
other colors (tail, orange, pink, white, purple). Neurons in A,B,G,H belong to layer V, while those in C,D, I, J belong to layer VI. E, F, K, L are higher
magnification images of basal dendrites located above—indicated with numbers (1 and 2)—demonstrating spine reconstructions. Mature spines are in
red, while immature spines are colored in green. Asterisks indicate basal dendrites with a significant decrease in mature spines (E2 and L2).
https://doi.org/10.1371/journal.pone.0183443.g002
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Statistics
The number of dendrites and spines in MAUab and MTDab cases was compared using T-test.
A p value of 0.05 was used for statistical significance.
Results
The dendritic arbor of pyramidal neurons in all layers of the prefrontal cortex (MTDab and
MAUab) was in general smaller in length and volume than those in the occipital cortex (Fig 1).
Pyramidal cells in each layer presented with similar dendritic length and volume, except for
those in layer VI that were noticeable smaller than in the other layers. We detected a difference
in length and volume of basal dendrites in layer V of the prefrontal cortex between the MAUab
group and the MTDab group. We did not find any change in the length and volume of apical
and basal dendrites in the rest of the layers, nor in the number of basal dendrites, the number
of dendrite terminations, or the number of bifurcations between the MAUab and the MTDab
groups.
The type of predominant spine type in both the MAUab and the MTDab groups were
mature spines (stubby and mushroom) while thin spines were lower in number in both apical
and basal dendrites (Fig 2). An exception to this was found in layer V of the occipital cortex
where thin spines outnumbered mature spines. A very small number of branched spines were
also present in most of the neurons. We did not find any change in the number or type of
spines in layers II and III in throughout the cortex, however we found a decrease in the num-
ber of specific spine types in the infragranular layers of the cortex when compared the MAUab
and MTDab groups.
Frontal cortex
We detected an alteration in the layer V of the frontal cortex of MAUab offspring. We did not
detect any changes in the remaining cortical layers (Figs 1, 2 and 3). The basal dendrites of
layer V neurons were decreased in length (48% decreased, MAUab, 51.01 ± 2.19, MTDab:
97.45 ± 11.95, p = 0.04) and volume (67% decreased, MAUab: 41.80 ± 5.0, MTDab: 126.55.45 ±
28.07, p = 0.01), and both the total number of spines and the spine density were lower than in
the control neurons. Basal dendrites in layer V in MAUab presented with a 57% decrease in the
total number of spines (MTDab: 279.5 ± 26.0, MAUab: 120.66 ± 17.5, p = 0.001). Spine density
was also lower in the MAUab group than in the control group (50% decreased, MTDab: 2.25 ±
0.1, MAUab: 1.14 ± 0.2, p = 0.005). Both the number of thin and mature spines were marginally
decreased (thin spines decreased 64%, MTDab: 179.5 ± 39, MAUab: 84.3 ± 13, p = 0.06; mature
spines decreased 50%, MTDab: 62.5 ± 12, MAUab: 31.5 ± 5 p = 0.07). We did not detect any
modification in length or volume nor in the total number of spines in the frontal cortex in api-
cal dendrites. To compensate for testing each individual hypothesis, we calculated the Bonfer-
roni adjusted P value for statistical significance as P 0.002. When using this P value the
decrease in the total number of spines in the basal dendrite was significant but not the spine
density.
Occipital cortex
We detected that in the occipital cortex of MAUab offspring there was an alteration in spines
in layer VI of the cortex. We did not detect any changes in the rest of cortical layers (Figs 1, 2
and 3). We found a 37% decrease in the total number of spines in the MAUab group compared
to the control group (MTDab: 97.83 ± 3.1, MAUab: 62.00 ± 12.7, p = 0.04), as well as a 32%
reduction in the spine density in the apical dendrite (MTDab: 0.25 ± 0.01, MAUab: 0.17± 0.01,
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Fig 3. The total number of spines in basal dendrites of layer V pyramidal neurons was lower than in
the control neurons. The total number of spines in apical and basal dendrites of layer VI pyramidal neurons
in the occipital cortex was also decreased. The decrease in spine number in the occipital cortex was only due
to a decrease in the number of mature spines. We did not find any change in other variables. Error bars (sem)
are represented. Interestingly, the time of exposure to these antibodies (E14.5) coincided with the time of
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p = 0.005) of pyramidal neurons in the occipital cortex. This decrease in spine number was
due to a decrease in the number of mature spines in the apical dendrite (46% decrease,
49.0 ± 2.4, MAUab: 26.6 ± 4.1, p = 0.001). We also found a decrease in the number of mature
spines in basal dendrites (60% decreased, MTDab: 89.5 ± 30, MAUab: 36.6 ± 3, p = 0.02). We
did not note any other changes in the occipital cortex. When using the Bonferroni P value of
significance, the decrease in the number of mature spines in the apical dendrite was significant
but not in the basal dendrites.
Overall, intraventricular administration of MAUab during mouse fetal development at
E14.5 did not affect dendrites or spines in the supragranular layers of the cortex, but we found
a consistent decrease in the number of spines in infragranular layers in both cortical areas of
interest, the frontal and occipital cortices. However, this alteration in spine number was only
specific to layer V in frontal cortex and only to layer VI in occipital cortex. The number of
mature spines and, to a lesser degree, the number of thin spines were affected. We also found a
decrease in the length and volume of layer V basal dendrites in the frontal cortex of MAUab
when compared to the MTDab treated mice.
Discussion
We found that intraventricular administration of MAUab during mid stages of neurogenesis in
mouse fetal development produced a consistent decrease in the number of spines in the infra-
granular layers in both cortical areas analyzed (frontal and occipital). The supragranular layers
were not affected by the single autoantibody treatment. The prefrontal cortex is a region well-
known to be affected in autism, while the occipital region has not yet been implicated. None-
theless, in our experiments MAUab administration affected both cortices, indicating that
MAUab interacted similarly with both cortical regions. However, this may not be the case in
human, since the method of intraventricular injection we used allows for the antibodies to
contact their target just for a limited time and bathes all the ventricular surface of the develop-
ing cortex. On the other hand, in humans there is a constant exposure to such antibodies and
it is still not known if all the antibodies contact all the cortical areas equally. Nevertheless, this
method allows us to evaluate what is the result of maternal autism-specific antibodies presence
in the brain during development. We previously reported that MAUab administration during
development affects neuronal soma size, and this increase affects neurons in all cortical regions
and layers [16]. We also demonstrated that intraventricular exposure to autism-specific mater-
nal autoantibodies produces autistic-like stereotypical behaviors in offspring mice [17].
Three main proteins have been discovered to be the ligands for the MAUab. One of them is
STIP1, which is first detected in the developing nervous system starting at E8 in the mouse
[40]. STIP1 is a major ligand of the cellular prion protein (PrP(C)) and together they mediate
neuritogenesis in cultured hippocampal neurons [41, 42]. Inhibition of this interaction leads
to impaired memory formation in rodents [43], while a STIP1 50% reduction produces ASD-
like phenotypes in mice, including hyperactive and attentional deficits [44]. STIP1 also modu-
lates proliferation of astrocytes and retinal cells, and is associated with glioblastoma [45–47].
STIP1 is abundantly expressed in the cytoplasm and has been recently found to be associated
with the actin cytoskeleton [48]. STIP1 directly interacts with the GTPase Rnd1, and overex-
pression of STIP1 prevents the Rnd1–plexin-A1-mediated cytoskeleton retraction. In PC-12
cells, overexpression of STIP1 enhances neurite outgrowth in the cellular processes initially
generation of pyramidal neurons in layer V in the frontal cortex and pyramidal neurons in layer VI in the
occipital cortex, following the normal rostro-caudal pattern of cortical cell generation. One asterisk: p < 0.05;
Two asterisks: p <0.01.
https://doi.org/10.1371/journal.pone.0183443.g003
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established by Rnd1. It can be inferred from these studies that STIP1 participates in the
Rnd1-induced signal transduction pathways that are involved in the dynamics of the actin
cytoskeleton [49]. Our results demonstrating alteration in the development of the dendritic
tree and the number of mature spines in the infragranular layers of the adult cortex after a
brief exposure to MAUab are in accordance with the neuritogenic function of STIP1, one of
the main targets of these antibodies.
Another major target of MAUab is the CRMP1 protein. The collapsin response mediator
proteins (CRMPs 1–5) are thought to contribute to semaphorin-induced growth cone collapse
[50], and are crucial for multiple neurodevelopmental processes. CRMP1 protein is highly
expressed in the developing brain where it is required for cell migration as well [50, 51]. A
third target of the MAUab is the mitochondrial enzyme lactate dehydrogenase (LDH), which is
found in fetal brain [52] where it functions in cellular metabolism. Although autoantibodies
targeting LDH have not yet been shown to play a direct role in altering neurodevelopment, the
need for energy during brain growth and development make LDH an interesting target for
MAUab.
We reasoned that the changes we noted in the dendritic arbor and in the number of mature
spines in infragranular layers of the cortex may be restricted to those layers because the time-
limited exposure to MAUab during cortical development in our study. When administering
antibodies in E14, we found dendritic and spine alterations in layer V in frontal cortex and in
layer VI in the occipital cortex. Interestingly, the time of exposure to these antibodies coincides
with the generation of pyramidal neurons in layer V in the frontal cortex and pyramidal neu-
rons in layer VI in the occipital cortex, following the normal rostro-caudal pattern of cortical
cell generation [53]. A reduction in the access of newborn cells to STIP1 in the developing cor-
tex at the time of antibody administration may be responsible for the reduced dendritic arbori-
zation and reduced number of spines we noted in the adult cortex. We predict that in human,
where MAUab are constantly present in the fetal brain during cortical development, the alter-
ations described in pyramidal cells of our time-limited model may be present in all the layers
of the cortex. Ideally, we will be following this study with an anatomical and pathology exami-
nation of a newly generated rodent model where the dam produces clinically relevant MAUab
throughout pregnancy and lactation. Results from these ongoing studies will further aid in the
determination of the pathologic mechanisms for MAU autism.
Author Contributions
Conceptualization: Vero´nica Martı´nez-Cerdeño.
Data curation: Jeanelle Ariza, Jesus Hurtado, Haille Rogers, Raymond Ikeda, Michael Dill,
Craig Steward, Donnay Creary.
Formal analysis: Vero´nica Martı´nez-Cerdeño.
Funding acquisition: Vero´nica Martı´nez-Cerdeño.
Investigation: Judy Van de Water, Vero´nica Martı´nez-Cerdeño.
Methodology: Jeanelle Ariza, Vero´nica Martı´nez-Cerdeño.
Project administration: Vero´nica Martı´nez-Cerdeño.
Resources: Judy Van de Water, Vero´nica Martı´nez-Cerdeño.
Supervision: Vero´nica Martı´nez-Cerdeño.
Validation: Vero´nica Martı´nez-Cerdeño.
Maternal antibodies effect in dendrite and spines
PLOS ONE | https://doi.org/10.1371/journal.pone.0183443 August 18, 2017 10 / 13
Writing – original draft: Vero´nica Martı´nez-Cerdeño.
Writing – review & editing: Judy Van de Water.
References
1. Baio J. Prevalence of Autism Spectrum Disorders—Autism and Developmental Disabilities Monitoring
Network, 14 Sites, United States, 2008. CDC MMWR, Surveillance Summaries. 2012; 61(SS03):1–19.
2. Blatt GJ. The neuropathology of autism. Scientifica (Cairo). 2012; 2012:703675. https://doi.org/10.
6064/2012/703675 PMID: 24278731; PubMed Central PMCID: PMCPMC3820437.
3. Amaral DG, Schumann CM, Nordahl CW. Neuroanatomy of autism. Trends in neurosciences. 2008; 31
(3):137–45. https://doi.org/10.1016/j.tins.2007.12.005 PMID: 18258309.
4. Maloney SE, Rieger MA, Dougherty JD. Identifying essential cell types and circuits in autism spectrum
disorders. Int Rev Neurobiol. 2013; 113:61–96. https://doi.org/10.1016/B978-0-12-418700-9.00003-4
PMID: 24290383; PubMed Central PMCID: PMCPMC3897614.
5. Hashemi E, Ariza J, Rogers H, Noctor SC, Martinez-Cerdeno V. The Number of Parvalbumin-Express-
ing Interneurons Is Decreased in the Medial Prefrontal Cortex in Autism. Cereb Cortex. 2016. https://
doi.org/10.1093/cercor/bhw021 PMID: 26922658.
6. Hashemi E, Ariza J, Lechpammer M, Noctor S, Martı´nez-Cerdeño V. Abnormal white matter tracts
resembling pencil fibers involving prefrontal cortex (BA47) in autism: a case report. Journal of Medical
Case Reports. 2016;In press.
7. Hutsler JJ, Casanova MF. Review: Cortical construction in autism spectrum disorder: columns, connec-
tivity and the subplate. Neuropathol Appl Neurobiol. 2015. https://doi.org/10.1111/nan.12227 PMID:
25630827.
8. Garty BZ, Ludomirsky A, Danon YL, Peter JB, Douglas SD. Placental transfer of immunoglobulin G sub-
classes. Clin Diagn Lab Immunol. 1994; 1(6):667–9. Epub 1994/11/01. PMID: 8556518; PubMed Cen-
tral PMCID: PMC368387.
9. Heininger U, Desgrandchamps D, Schaad UB. Seroprevalence of Varicella-Zoster virus IgG antibodies
in Swiss children during the first 16 months of age. Vaccine. 2006; 24(16):3258–60. Epub 2006/02/07.
S0264-410X(06)00030-2 [pii] https://doi.org/10.1016/j.vaccine.2006.01.026 PMID: 16459000.
10. Dalton P, Deacon R, Blamire A, Pike M, McKinlay I, Stein J, et al. Maternal neuronal antibodies associ-
ated with autism and a language disorder. Annals of neurology. 2003; 53(4):533–7. Epub 2003/04/01.
https://doi.org/10.1002/ana.10557 PMID: 12666123.
11. Singer HS, Morris CM, Gause CD, Gillin PK, Crawford S, Zimmerman AW. Antibodies against fetal
brain in sera of mothers with autistic children. Journal of neuroimmunology. 2008; 194(1–2):165–72.
Epub 2007/12/21. S0165-5728(07)00424-9 [pii] https://doi.org/10.1016/j.jneuroim.2007.11.004 PMID:
18093664.
12. Braunschweig D, Ashwood P, Krakowiak P, Hertz-Picciotto I, Hansen R, Croen LA, et al. Autism: mater-
nally derived antibodies specific for fetal brain proteins. Neurotoxicology. 2008; 29(2):226–31. Epub
2007/12/15. S0161-813X(07)00244-6 [pii] https://doi.org/10.1016/j.neuro.2007.10.010 PMID:
18078998; PubMed Central PMCID: PMC2305723.
13. Croen LA, Braunschweig D, Haapanen L, Yoshida CK, Fireman B, Grether JK, et al. Maternal mid-preg-
nancy autoantibodies to fetal brain protein: the early markers for autism study. Biol Psychiatry. 2008; 64
(7):583–8. Epub 2008/06/24. S0006-3223(08)00580-5 [pii] https://doi.org/10.1016/j.biopsych.2008.05.
006 PMID: 18571628; PubMed Central PMCID: PMC2574992.
14. Braunschweig D, Krakowiak P, Duncanson P, Boyce R, Hansen R, Ashwood P, et al. Autism-Specific
Maternal Autoantibodies Recognize Critical Proteins in Developing Brain. Translational Psychiatry.
2013;in press.
15. Bauman MD, Iosif AM, Ashwood P, Braunschweig D, Lee A, Schumann CM, et al. Maternal antibodies
from mothers of children with autism alter brain growth and social behavior development in the rhesus
monkey. Transl Psychiatry. 2013; 3:e278. https://doi.org/10.1038/tp.2013.47 PMID: 23838889;
PubMed Central PMCID: PMC3731783.
16. Martinez-Cerdeno V, Camacho J, Fox E, Miller E, Ariza J, Kienzle D, et al. Prenatal Exposure to
Autism-Specific Maternal Autoantibodies Alters Proliferation of Cortical Neural Precursor Cells,
Enlarges Brain, and Increases Neuronal Size in Adult Animals. Cereb Cortex. 2016; 26(1):374–83.
https://doi.org/10.1093/cercor/bhu291 PMID: 25535268; PubMed Central PMCID: PMC4677982.
17. Camacho J, Jones K, Miller E, Ariza J, Noctor S, Van de Water J, et al. Embryonic intraventricular expo-
sure to autism-specific maternal autoantibodies produces alterations in autistic-like stereotypical behav-
iors in offspring mice. Behav Brain Res. 2014; 266C:46–51. https://doi.org/10.1016/j.bbr.2014.02.045
PMID: 24613242.
Maternal antibodies effect in dendrite and spines
PLOS ONE | https://doi.org/10.1371/journal.pone.0183443 August 18, 2017 11 / 13
18. Guillery RW. Early electron microscopic observations of synaptic structures in the cerebral cortex: a
view of the contributions made by George Gray (1924–1999). Trends in neurosciences. 2000; 23
(12):594–8. PMID: 11137148.
19. Gray EG. Axosomatic and axodendritic synapses in the cerebral cortex. J Anat. 1959; 93:420–33.
PMID: 13829103
20. Segev I, London M. Untangling dendrites with quantitative models. Science. 2000; 290(5492):744–50.
PMID: 11052930.
21. Gulledge AT, Kampa BM, Stuart GJ. Synaptic integration in dendritic trees. Journal of neurobiology.
2005; 64(1):75–90. https://doi.org/10.1002/neu.20144 PMID: 15884003.
22. Sabatini BL, Svoboda K. Analysis of calcium channels in single spines using optical fluctuation analysis.
Nature. 2000; 408(6812):589–93. https://doi.org/10.1038/35046076 PMID: 11117746.
23. Sala C, Segal M. Dendritic spines: the locus of structural and functional plasticity. Physiological reviews.
2014; 94(1):141–88. https://doi.org/10.1152/physrev.00012.2013 PMID: 24382885.
24. Luebke JI, Weaver CM, Rocher AB, Rodriguez A, Crimins JL, Dickstein DL, et al. Dendritic vulnerability
in neurodegenerative disease: insights from analyses of cortical pyramidal neurons in transgenic
mouse models. Brain structure & function. 2010; 214(2–3):181–99. https://doi.org/10.1007/s00429-
010-0244-2 PMID: 20177698; PubMed Central PMCID: PMC3045830.
25. Chang FL, Greenough WT. Transient and enduring morphological correlates of synaptic activity and
efficacy change in the rat hippocampal slice. Brain research. 1984; 309(1):35–46. PMID: 6488013.
26. Nimchinsky EA, Sabatini BL, Svoboda K. Structure and function of dendritic spines. Annual review of
physiology. 2002; 64:313–53. https://doi.org/10.1146/annurev.physiol.64.081501.160008 PMID:
11826272.
27. Trachtenberg JT, Chen BE, Knott GW, Feng G, Sanes JR, Welker E, et al. Long-term in vivo imaging of
experience-dependent synaptic plasticity in adult cortex. Nature. 2002; 420(6917):788–94. https://doi.
org/10.1038/nature01273 PMID: 12490942.
28. Kasai H, Matsuzaki M, Noguchi J, Yasumatsu N, Nakahara H. Structure-stability-function relationships
of dendritic spines. Trends in neurosciences. 2003; 26(7):360–8. https://doi.org/10.1016/S0166-2236
(03)00162-0 PMID: 12850432.
29. Rochefort NL, Konnerth A. Dendritic spines: from structure to in vivo function. EMBO reports. 2012; 13
(8):699–708. https://doi.org/10.1038/embor.2012.102 PMID: 22791026; PubMed Central PMCID:
PMC3410382.
30. Martinez-Cerdeno V. Dendrite and spine modifications in autism and related neurodevelopmental disor-
ders in patients and animal models. Developmental neurobiology. 2016. https://doi.org/10.1002/dneu.
22417 PMID: 27390186.
31. Raymond GV, Bauman ML, Kemper TL. Hippocampus in autism: a Golgi analysis. Acta Neuropathol.
1996; 91(1):117–9. Epub 1996/01/01. PMID: 8773156.
32. Williams RS, Hauser SL, Purpura DP, DeLong GR, Swisher CN. Autism and mental retardation: neuro-
pathologic studies performed in four retarded persons with autistic behavior. Archives of neurology.
1980; 37(12):749–53. Epub 1980/12/01. PMID: 7447762.
33. Mukaetova-Ladinska E, B., Arnold H, Jaros E, Perry R, Perry E. Depletion of MAP2 expression and lam-
inar cytoarchitectonic changes in dorsolateral prefrontal cortex in adult autistic individuals. Neuropathol
Appl Neurobiol. 2004; 30(6):615–23. https://doi.org/10.1111/j.1365-2990.2004.00574.x PMID:
15541002
34. Hutsler JJ, Zhang H. Increased dendritic spine densities on cortical projection neurons in autism spec-
trum disorders. Brain research. 2010; 1309:83–94. Epub 2009/11/10. S0006-8993(09)02311-7 [pii]
https://doi.org/10.1016/j.brainres.2009.09.120 PMID: 19896929.
35. Noctor SC, Flint AC, Weissman TA, Dammerman RS, Kriegstein AR. Neurons derived from radial glial
cells establish radial units in neocortex. Nature. 2001; 409(6821):714–20. Epub 2001/02/24. https://doi.
org/10.1038/35055553 PMID: 11217860.
36. Noctor SC, Martinez-Cerdeno V, Ivic L, Kriegstein AR. Cortical neurons arise in symmetric and asym-
metric division zones and migrate through specific phases. Nature neuroscience. 2004; 7(2):136–44.
Epub 2004/01/03. https://doi.org/10.1038/nn1172 PMID: 14703572.
37. Noctor SC, Martinez-Cerdeno V, Kriegstein AR. Distinct behaviors of neural stem and progenitor cells
underlie cortical neurogenesis. The Journal of comparative neurology. 2008; 508(1):28–44. https://doi.
org/10.1002/cne.21669 PMID: 18288691.
38. Gibb R, Kolb B. A method for vibratome sectioning of Golgi-Cox stained whole rat brain. J Neurosci
Methods. 1998; 79(1):1–4. Epub 1998/04/08. S0165027097001635 [pii]. PMID: 9531453.
39. Dall’Oglio A, Ferme D, Brusco J, Moreira JE, Rasia-Filho AA. The "single-section" Golgi method
adapted for formalin-fixed human brain and light microscopy. J Neurosci Methods. 2010; 189(1):51–5.
Maternal antibodies effect in dendrite and spines
PLOS ONE | https://doi.org/10.1371/journal.pone.0183443 August 18, 2017 12 / 13
Epub 2010/03/30. S0165-0270(10)00152-4 [pii] https://doi.org/10.1016/j.jneumeth.2010.03.018 PMID:
20347871.
40. Hajj GN, Santos TG, Cook ZS, Martins VR. Developmental expression of prion protein and its ligands
stress-inducible protein 1 and vitronectin. The Journal of comparative neurology. 2009; 517(3):371–84.
Epub 2009/09/18. https://doi.org/10.1002/cne.22157 PMID: 19760599.
41. Lopes MH, Hajj GN, Muras AG, Mancini GL, Castro RM, Ribeiro KC, et al. Interaction of cellular prion
and stress-inducible protein 1 promotes neuritogenesis and neuroprotection by distinct signaling path-
ways. The Journal of neuroscience: the official journal of the Society for Neuroscience. 2005; 25
(49):11330–9. Epub 2005/12/13. https://doi.org/10.1523/JNEUROSCI.2313-05.2005 PMID: 16339028.
42. Roffe M, Beraldo FH, Bester R, Nunziante M, Bach C, Mancini G, et al. Prion protein interaction with
stress-inducible protein 1 enhances neuronal protein synthesis via mTOR. Proceedings of the National
Academy of Sciences of the United States of America. 2010; 107(29):13147–52. Epub 2010/07/10.
https://doi.org/10.1073/pnas.1000784107 PMID: 20615969; PubMed Central PMCID: PMC2919922.
43. Coitinho AS, Lopes MH, Hajj GN, Rossato JI, Freitas AR, Castro CC, et al. Short-term memory forma-
tion and long-term memory consolidation are enhanced by cellular prion association to stress-inducible
protein 1. Neurobiology of disease. 2007; 26(1):282–90. Epub 2007/03/03. https://doi.org/10.1016/j.
nbd.2007.01.005 PMID: 17329112.
44. Beraldo FH, Thomas A, Kolisnyk B, Hirata PH, De Jaeger X, Martyn AC, et al. Hyperactivity and atten-
tion deficits in mice with decreased levels of stress-inducible phosphoprotein 1 (STIP1). Disease mod-
els & mechanisms. 2015; 8(11):1457–66. https://doi.org/10.1242/dmm.022525 PMID: 26398952;
PubMed Central PMCID: PMC4631792.
45. Arantes C, Nomizo R, Lopes MH, Hajj GN, Lima FR, Martins VR. Prion protein and its ligand stress
inducible protein 1 regulate astrocyte development. Glia. 2009; 57(13):1439–49. Epub 2009/02/27.
https://doi.org/10.1002/glia.20861 PMID: 19243016.
46. Arruda-Carvalho M, Njaine B, Silveira MS, Linden R, Chiarini LB. Hop/STI1 modulates retinal prolifera-
tion and cell death independent of PrPC. Biochem Biophys Res Commun. 2007; 361(2):474–80. Epub
2007/07/27. https://doi.org/10.1016/j.bbrc.2007.07.038 PMID: 17651690.
47. Erlich RB, Kahn SA, Lima FR, Muras AG, Martins RA, Linden R, et al. STI1 promotes glioma prolifera-
tion through MAPK and PI3K pathways. Glia. 2007; 55(16):1690–8. Epub 2007/09/22. https://doi.org/
10.1002/glia.20579 PMID: 17886292.
48. Willmer T, Contu L, Blatch GL, Edkins AL. Knockdown of Hop downregulates RhoC expression, and
decreases pseudopodia formation and migration in cancer cell lines. Cancer letters. 2013; 328(2):252–
60. https://doi.org/10.1016/j.canlet.2012.09.021 PMID: 23036489.
49. de Souza LE, Moura Costa MD, Bilek ES, Lopes MH, Martins VR, Puschel AW, et al. STI1 antagonizes
cytoskeleton collapse mediated by small GTPase Rnd1 and regulates neurite growth. Experimental cell
research. 2014; 324(1):84–91. https://doi.org/10.1016/j.yexcr.2014.03.017 PMID: 24690281.
50. Quach TT, Duchemin AM, Rogemond V, Aguera M, Honnorat J, Belin MF, et al. Involvement of collap-
sin response mediator proteins in the neurite extension induced by neurotrophins in dorsal root ganglion
neurons. Mol Cell Neurosci. 2004; 25(3):433–43. Epub 2004/03/23. https://doi.org/10.1016/j.mcn.2003.
11.006 PMID: 15033171.
51. Charrier E, Reibel S, Rogemond V, Aguera M, Thomasset N, Honnorat J. Collapsin response mediator
proteins (CRMPs): involvement in nervous system development and adult neurodegenerative disor-
ders. Mol Neurobiol. 2003; 28(1):51–64. Epub 2003/09/30. https://doi.org/10.1385/MN:28:1:51 PMID:
14514985.
52. Hashimoto T, Hussien R, Cho HS, Kaufer D, Brooks GA. Evidence for the mitochondrial lactate oxida-
tion complex in rat neurons: demonstration of an essential component of brain lactate shuttles. PloS
one. 2008; 3(8):e2915. Epub 2008/08/14. https://doi.org/10.1371/journal.pone.0002915 PMID:
18698340; PubMed Central PMCID: PMC2488371.
53. Martinez-Cerdeno V, Cunningham CL, Camacho J, Antczak JL, Prakash AN, Cziep ME, et al. Compar-
ative analysis of the subventricular zone in rat, ferret and macaque: evidence for an outer subventricular
zone in rodents. PloS one. 2012; 7(1):e30178. Epub 2012/01/25. https://doi.org/10.1371/journal.pone.
0030178 PMID: 22272298; PubMed Central PMCID: PMC3260244.
Maternal antibodies effect in dendrite and spines
PLOS ONE | https://doi.org/10.1371/journal.pone.0183443 August 18, 2017 13 / 13
